Cargando…
Elimination of Ox-LDL through the liver inhibits advanced atherosclerotic plaque progression
Aim: In the late stage of atherosclerosis, the endothelial barrier of plaque is destroyed. The rapid deposition of oxidized lipids in the circulation leads to migration of numerous smooth muscle cells and macrophages, as well as foaming necrosis. The plaque progresses rapidly, and vulnerable plaques...
Autores principales: | Wang, Zhiwen, Guo, Xiaopeng, Zhang, Qing, Du, Gaohui, Zeng, Zhuanglin, Zheng, Chuansheng, Wei, Yumiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579296/ https://www.ncbi.nlm.nih.gov/pubmed/34790037 http://dx.doi.org/10.7150/ijms.63065 |
Ejemplares similares
-
The LOX-1 receptor ectopically expressed in the liver alleviates atherosclerosis by clearing Ox-LDL from the circulation
por: Wang, Zhiwen, et al.
Publicado: (2022) -
Reducing the Damage of Ox-LDL/LOX-1 Pathway to Vascular Endothelial Barrier Can Inhibit Atherosclerosis
por: Guo, Xiaopeng, et al.
Publicado: (2022) -
Investigation of highly expressed PCSK9 in atherosclerotic plaques and ox-LDL-induced endothelial cell apoptosis
por: Li, Jiao, et al.
Publicado: (2017) -
An Inhibitor of Grp94 Inhibits OxLDL-Induced Autophagy and Apoptosis in VECs and Stabilized Atherosclerotic Plaques
por: Wei, Qun, et al.
Publicado: (2021) -
Passive Immunization with Hypochlorite-oxLDL Specific Antibodies Reduces Plaque Volume in LDL Receptor-Deficient Mice
por: van Leeuwen, Marcella, et al.
Publicado: (2013)